BIOMATRIX SUPPORT ADRENALS

Serial Number 88135021
Registration 5745197
700

Registration Progress

Application Filed
Sep 27, 2018
Under Examination
Approved for Publication
Feb 19, 2019
Published for Opposition
Feb 19, 2019
Registered
May 7, 2019

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2019-05-07)
Due: May 07, 2025 Overdue

Basic Information

Serial Number
88135021
Registration Number
5745197
Filing Date
September 27, 2018
Registration Date
May 7, 2019
Published for Opposition
February 19, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
May 7, 2019
Registration
Registered
Classes
005

Rights Holder

BIOMATRIX INTERNATIONAL, LLC

16
Address
1620 CENTRAL AVE. SUITE 202
CHEYENNE, WY 82001

Ownership History

IP Home LLC

Original Applicant
16
Cheynne, WY

IP Home LLC

Owner at Publication
16
Cheynne, WY

IP Home LLC

Original Registrant
16
Cheynne, WY

BIOMATRIX INTERNATIONAL, LLC

New Owner After Registration #1
16
CHEYENNE, WY

Legal Representation

Attorney
mathew auric

USPTO Deadlines

Next Deadline
1398 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2019-05-07)
Due Date
May 07, 2029
Grace Period Ends
November 07, 2029

Application History

18 events
Date Code Type Description
May 7, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 28, 2021 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
May 7, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER
Feb 19, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 19, 2019 PUBO A PUBLISHED FOR OPPOSITION
Jan 30, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 11, 2019 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 11, 2019 ALIE A ASSIGNED TO LIE
Dec 16, 2018 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 11, 2018 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 11, 2018 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN
Dec 11, 2018 XAEC I EXAMINER'S AMENDMENT ENTERED
Dec 11, 2018 CNEA R EXAMINERS AMENDMENT -WRITTEN
Dec 11, 2018 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 11, 2018 GNEA F EXAMINERS AMENDMENT E-MAILED
Dec 7, 2018 DOCK D ASSIGNED TO EXAMINER
Oct 5, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 1, 2018 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Nutraceuticals for use as a dietary supplement
First Use Anywhere: Jan 14, 2000
First Use in Commerce: Jan 14, 2000

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"SUPPORT ADRENALS"